Vitaspring Biomedical Statements
VS
Vitaspring Biomedical Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
100
—
0
—
0
—
0
0.183
0
0.183
0
-0.183
0
—
0
-0.001
0
-0.184
0
-0.046
0
-0.138
0
-0.001
206.52
1.49
100
0.922
61.9
0.568
38.1
—
0
0.4
26.8
0.4
26.8
0.168
11.3
—
0
0.009
0.6
0.177
11.9
0.045
3
0.132
8.9
0.001
206.52
1.49
100
0.922
61.9
0.568
38.1
—
0
0.221
14.8
0.225
15.1
0.343
23
—
0
0.009
0.6
0.352
23.6
0.075
5
0.277
18.6
0.001
206.52
3.489
100
2.022
58
1.467
42
—
0
0.278
8
0.279
8
1.188
34.1
—
0
—
0
1.188
34.1
0.247
7.1
0.941
27
0.005
206.53
0.2
100
0.18
89.8
0.02
10.2
—
0
0.157
78.4
0.157
78.6
-0.137
-68.4
—
0
—
0
-0.137
-68.4
—
0
-0.137
-68.4
-0.001
206.52
1.924
100
1.343
69.8
0.581
30.2
—
0
0.149
7.8
0.151
7.8
0.43
22.3
—
0
—
0
0.43
22.3
-0.03
-1.5
0.46
23.9
0.002
206.16
0.534
100
0.294
55.1
0.24
44.9
—
0
0.06
11.2
0.06
11.3
0.179
33.6
—
0
—
0
0.179
33.6
0.004
0.8
0.175
32.8
0.001
205.45